The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999
Elkin E.B., Hudis C., Begg C.B., et al. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer 104 (2005) 1149-1157
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy
Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy
Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 50 (2001) 1003-1011
The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer
Vaidya J.S., Baum M., Tobias J.S., et al. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Euro J Surg Oncol 8 (2002) 447-454
Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy
Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 (2003) 1247-1253
A permanent breast seed implant as partial breast radiation therapy for early-stage patients: A comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations
Keller B., Sankreacha R., Rakovitch E., et al. A permanent breast seed implant as partial breast radiation therapy for early-stage patients: A comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations. Int J Radiat Oncol Biol Phys 62 (2005) 358-365
First report of a permanent breast Pd-103 seed implant as adjuvant radiation treatment for early-stage breast cancer
Pignol J.P., Keller B., Rakovitch E., et al. First report of a permanent breast Pd-103 seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 64 (2006) 176-181
National Council on Radiation Protection and Measurements Commentary #11. Dose limits for individuals who receive exposure from radionuclide therapy patients. Available at: http://www.ncrponline.org/Publications/Comm11press.html. Accessed November 5, 2004.
10
0026756899
Effective dose and effective dose equivalent-The impact of the new ICRP definition for external photon irradiation
Zankl M., Petoussi N., and Drexler G. Effective dose and effective dose equivalent-The impact of the new ICRP definition for external photon irradiation. Health Phys 62 (1992) 395-399
International Commission on Radiation Units and Measurements Report 43. Determination of dose equivalents from external radiation sources-Part 2. Section 5. Bethesda, MD; December 15, 1988.
* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.